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The endoplasmic reticulum (ER) is an important player in regulating protein synthesis and
lipid metabolism. Perturbation of ER homeostasis, referred as “ER stress,” has been linked
to numerous pathological conditions, such as inﬂammation, cardiovascular diseases, and
metabolic disorders.The liver plays a central role in regulating nutrient and lipidmetabolism.
Accumulating evidence implicates that ER stress disrupts lipid metabolism and induces
hepatic lipotoxicity. Here, we review themajor ER stress signaling pathways, howER stress
contributes to the dysregulation of hepatic lipid metabolism, and the potential causative
mechanisms of ER stress in hepatic lipotoxicity. Understanding the role of ER stress in
hepatic metabolism may lead to the identiﬁcation of new therapeutic targets for metabolic
diseases.
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INTRODUCTION
Endoplasmic reticulum is an important intracellular organelle
responsible for protein synthesis, folding, modiﬁcation, and
trafﬁcking. In addition, the ER also plays a crucial role in cal-
cium homeostasis and in regulating the biosynthesis of steroids,
lipids and carbohydrates (Borgese et al., 2006). In the ER, mil-
lions of proteins are synthesized, but not all of them are able
to be properly folded and processed. Under normal physiologi-
cal conditions, the unfolded or misfolded proteins are directed
to degradation pathways through activating an evolutionally con-
served signaling pathway, the UPR. Activation of the UPR can
either help eliminate the unfolded proteins and restore cellu-
lar homeostasis, or activate a cascade of intracellular events
resulting in cell death (Shen et al., 2004; Merksamer and Papa,
2010). The UPR is of particular importance in hepatocytes,
which are rich in ER content and responsible for the synthe-
sis of proteins, cholesterol, bile acids, and phospholipids. The
UPR and its contribution to hepatic injury have been investi-
gated in various liver diseases including ALD, NAFLD, DILD,
cholestatic liver disease, and viral hepatitis (Zhou et al., 2006;
Kaplowitz et al., 2007; Colgan et al., 2011; Dara et al., 2011; Jo
et al., 2013).
Abbreviations: ABCA1, ATP-binding cassette, sub-family A, member 1; ACC,
acetyl-CoA carboxylase; ALD, alcoholic liver disease; ATF, activating transcrip-
tion factor; C/EBP, CCAAT/enhancer-binding protein; CHOP, C/EBP homologous
protein; DILD, drug-induced liver disease; eIF2α, eukaryotic translation initia-
tion factor; ER, endoplasmic reticulum; FAS, fatty acid synthase; FXRα, farnesold
X receptor α; GADD, growth arrest and DNA damage-inducible protein; HDL,
high density lipoprotein; Insig, insulin-induced gene; IRE1, inositol requir-
ing enzyme 1; JNK, c-Jun N-terminal kinase; LDL, low density lipoprotein;
MCD, methionine-choline-deﬁcient diet; NAFLD, non-alcoholic fatty liver dis-
ease; PERK, protein kinase RNA-like ER kinase; S1P, site 1 protease; S2P, site 2
protease; SCAP, SREBP cleavage activating protein; SCD, stearoyl-CoA desaturase;
SREBP, sterol regulatory element binding protein; UPR, unfolded protein response;
VLDL, very low density lipoprotein; VLDLR, VLDL receptor; XBP, X-box binding
protein.
ER STRESS AND THE UPR
The ER is a membranous network of cisternae responsible for
the synthesis and export of proteins and lipids. It is also crucial
for cellular calcium homeostasis (Borgese et al., 2006; Gorlach
et al., 2006). The ability of the ER to adapt to the metabolic
changes, such as an increase in protein synthesis and accumu-
lation of unfolded proteins and cholesterol in the ER lumen, is
of paramount importance for the cell. When the misfolded or
unfolded proteins accumulate in the ER, the ER stress and its
related signaling pathways, UPR, are activated (Ron and Walter,
2007; Schroder, 2008).
Three main branches of the UPR-mediated signaling pathways
have been identiﬁed so far: the IRE1 pathway, protein kinase RNA-
like ER kinase (PERK) pathway, and ATF6 pathway. As illustrated
in Figure 1, IRE1, PERK, and ATF6 are associated with the ER
membrane. Under non-stressed condition, these transmembrane
proteins are bound to a chaperone protein, BiP/GRP78, which is
also known as the master regulator of the UPR. The binding of
BiP/GRP78 to these UPR transducers prevents them from activa-
tion. When the ER is stressed by accumulation of misfolded or
unfolded proteins, depletion of ER calcium content, or increase
of free cholesterol in the ER lumen, BiP/GRP78 is released from
the UPR transducers. The disassociation of BiP/GRP78 from the
UPR transducers results in the activation of IRE1-, PERK-, and
ATF6-mediated signaling pathways. PERK activation results in
a rapid down-regulation of protein synthesis via phosphoryla-
tion of eIF-2α and inhibition of the formation of the translation
initiation complex (DuRose et al., 2009). The phosphorylated
eIF-2α further promotes the translation of ATF4, a member of
the basic leucine zipper (bZIP)-containing protein subfamily.
IRE1α has both protein kinase and endoribonuclease activities.
Under ER stress conditions, IRE1α is oligomerized and autophos-
phorylated. The activated IRE1α removes a 26-bp intron from
the XBP1 mRNA, resulting in the production of spliced XBP1
protein (XBP1s). XBP1s, which is also a bZIP transcription factor,
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FIGURE 1 | Schematic diagram of the ER stress-activated signaling
pathways.
regulates the expression of several genes involved in UPR and
ER-assisted degradation (ERAD) to help restore ER homeostasis
(Acosta-Alvear et al., 2007). In addition, IRE1α also induces the
activation of stress kinases, JNK and p38 MAPK, that promote
apoptosis (Ron and Hubbard, 2008). ATF6 is the third branch
of the UPR. Dissociation of BiP/GRP78 from ATF6 leads to its
translocation to the Golgi, where it is processed into its active
form by cleavage of its N-terminal domain by S1P and S2P (Chen
et al., 2002). The activated ATF6 (ATF-6 N terminal domain) is
translocated to the nucleus and functions as a transcription factor,
promoting the expression of downstream target genes involved
in ER stress including XBP1, GADD153 (also known as CHOP),
and ER chaperones (Oyadomari and Mori, 2004). CHOP is a
proapoptotic transcription factor that plays a critical role in ER
stress-mediated apoptosis (Marciniak et al., 2004).
HEPATIC LIPID METABOLISM
Liver is the central metabolic organ and plays a critical role in
fatty acid and cholesterol metabolism (Hylemon et al., 2001).
Several inter-dependent pathways are involved in hepatic lipid
metabolism. The hepatic fatty acids can be derived from de
novo lipogenesis, hydrolysis of triglyceride from cytoplasmic lipid
droplets or direct uptake of non-esteriﬁed fatty acids from circula-
tion (Bechmann et al., 2012). The liver is also a major organ in the
processing of lipids into the various lipoproteins, in particular
VLDL and LDL. Fatty acids synthesized by the liver are con-
verted into triglyceride and exported as constituents of VLDL
into the blood circulation. The VLDLs absorbed into periph-
eral tissues are partially digested by lipoprotein lipase into LDL
and free fatty acids. LDL is transported into the cell via LDL
receptors for its conversion into free fatty acids, cholesterol, and
other components of LDL. Similarly, cholesterol also can be
derived from de novo synthesis or absorbed from the diet, and
are transported into circulation as lipoprotein particles (Hor-
ton et al., 2002a; Babin and Gibbons, 2009; van Heyningen,
2009; Musso et al., 2013; Faust and Kovacs, 2014). The choles-
terol can be stored in cells as cholesterol esters or metabolized
into bile acids. The hepatic triglycerides and cholesterol contents
are tightly regulated by multiple interrelated signaling pathways.
Under normal physiological conditions, lipid input is equal to
lipid output from the body. Disruption of either the input or
output pathways will result in dysregulation of lipid metabolism
(Hylemon et al., 2001). Tremendous studies have been done to elu-
cidate the extremely complex regulation network of hepatic lipid
homeostasis (Bradbury and Berk, 2004; Bradbury, 2006; Weick-
ert and Pfeiffer, 2006; Nguyen et al., 2008; Musso et al., 2009;
Sparks and Dong, 2009; vanHeyningen, 2009; Trauner et al., 2010;
Jump, 2011; Fu et al., 2012). Here, we will focus on the current
understanding regarding the role of ER stress in hepatic lipid
metabolism.
UPR AND HEPATIC LIPID HOMEOSTASIS
The ER is the primary site of lipid metabolism. Many enzymes
and regulatory proteins of lipid metabolism reside in the ER.
Perturbation of ER homeostasis contributes to hepatic steato-
sis, inﬂammation and insulin resistance in the liver (Kaplowitz
et al., 2007; Hotamisligil, 2010; Rohrl et al., 2014). Although the
UPR was originally identiﬁed as a conserved signaling pathway,
functioning tomaintain essential ERhomeostasis, numerous stud-
ies indicate that the UPR has broader functions and plays an
essential role in maintaining hepatic lipid homeostasis. Recent
studies have shown that the pharmacologic ER stress inducers
increase de novo lipogenesis and lipid droplet formation in hepa-
tocytes by up-regulating a subset of genes encoding key lipogenic
trans-activators and enzymes (Lee et al., 2012).
Hepatic lipid homeostasis is controlled by numerous tran-
scription factors and nuclear receptors. The SREBPs are master
regulators of lipid homeostasis (Eberle et al., 2004) and play a
critical role in de novo lipid biosynthesis (Amemiya-Kudo et al.,
2002). SREBP-1 controls fatty acid and triglyceride biosynthesis,
while SREBP-2 controls cholesterol metabolism and LDL recep-
tor expression. SREBPs, are basic-helix-loop-helix-leucine zipper
(bHLHLZ) transcription factors bound to the ER membranes
as an inactive precursor (Brown and Goldstein, 1997). The reg-
ulation of SREBP activity is controlled within the ER by the
interaction of SCAP with insulin regulated proteins (Insigs; Yang
et al., 2002). The Insigs can cause ER retention of the SREBP-
SCAP complex and prevent the activation of SREBPs. When
the sterol level is low, Insigs are disassociated with SCAP, which
allows the SREBP-SCAP complex to migrate to the Golgi, where
SREBPs are processed into active forms by S1P and S2P (Rawson,
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2003; Lee and Ye, 2004). The activated SREBPs are subsequently
translocated into nucleus, where SREBPs regulate the expres-
sion of various genes involved in lipid metabolism by binding
to the sterol regulatory element of their target genes (Horton
et al., 2002a,b; Radhakrishnan et al., 2007). It has been shown
that ER stress induces proteolytic activation of SREBPs by increas-
ing the turnover of Insig-1 (Lee and Ye, 2004). The expression of
Insigs is regulated by insulin and FXRα (Yabe et al., 2003; Hubbert
et al., 2007). Overexpression of hepatic Insigs has been shown to
reduce hepatic lipogenesis (Engelking et al., 2004; Takaishi et al.,
2004).
ER stress and lipid metabolism are tightly intertwined. The
chronic ER stress is the most important contributor to metabolic
diseases. Unresolved ER stress induces dysregulation of hepatic
lipid metabolism (Fu et al., 2012). It is also well-documented that
excess saturated fatty acids and cholesterol can induce ER stress
and disrupt lipid metabolism in hepatocytes, macrophages and
adipocytes (Fribley et al., 2009; Colgan et al., 2011; Anderson et al.,
2012; Fu et al., 2012; Wang et al., 2013; Zha et al., 2013). The vari-
ous components of the UPR signaling pathways play a role in the
regulation of lipid metabolism.
IRE1α-XBP1 PATHWAY
IRE1α-XBP1 pathway is one of three main branches of UPR,
which has been identiﬁed as a critical regulator of hepatic lipid
metabolism. Hepatic-speciﬁc deletion of IRE1α increased hep-
atic lipid levels and reduced plasma lipid by altering several genes
involved in hepatic lipid metabolism under ER stress conditions
such as C/EBPβ, C/EBPδ, peroxisome proliferator-activated recep-
tor γ (PPARγ), and enzymes involved in triglyceride biosynthesis
(Zhang et al., 2011). Although, these results suggest a plausible
protective role of IRE1α from hepatic steatosis, the deletion of
IRE1α blocks the basal level of the UPR in liver which may lead
to an unresolved ER stress. Thus, it is still unclear whether the
induction of lipogenesis genes in IRE1α−/− mice is due to the
loss of IRE1α function or elevated ER stress. Studies done by
Lee et al. (2008) reported that disruption of hepatic XBP-1 sig-
niﬁcantly reduced serum triglyceride, cholesterol and fatty acids
levels by decreasing de novo hepatic lipogenesis in mice. In addi-
tion, the IRE1α-XBP1 pathway is also involved in regulation of
hepatic VLDL assembly and secretion (Wang et al., 2012). IRE1α
is required for efﬁcient secretion of VLDL and LDL from hep-
atocytes under the condition of ER stress (Zhang et al., 2011). A
most recent study done by Rohrl et al. (2014) identiﬁed novel links
between ER stress and hepatic cholesterol metabolism. Activation
of acute ER stress reducedABCA1 expression and inducedABCA1
redistribution to tubular perinuclear compartments in hepato-
cytes, which signiﬁcantly diminished cholesterol efﬂux to apoA-I
and HDL formation (Rohrl et al., 2014).
PERK-ATF-4 PATHWAY
Protein kinase RNA-like ER kinase activation induces eIF2α phos-
phorylation, which causes translation attenuation that is required
to protect against apoptosis in response to ER stress. Although
the exact role of PERK in hepatic steatosis is still not completely
understood, a recent report also suggests that antipsychotic drugs
(APDs)-induced activation of PERK-p-eIF2α signaling pathway
increases intracellular lipid accumulation through activation of
SREBP-1c and SREBP-2 in hepatocytes (Lauressergues et al.,
2012). Attenuation of eIF2α in GADD34 transgenic mice sig-
niﬁcantly altered the metabolism proﬁle and reduced high fat
diet-inducedhepatic steatosis (Oyadomari et al., 2008). As adown-
stream transcriptional factor of the UPR, ATF4 avoids global
suppression of protein expression induced by p-eIF2α due to a
different upstream signaling pathway. It has been shown thatATF4
deﬁciency preferentially attenuated hepatic lipogenesis via down-
regulationof PPARγ, SREBP-1c,ACCandSCDexpressionwithout
affecting hepatic triglyceride production and fatty acid oxidation
(Li et al., 2011; Xiao et al., 2013). A recent study further identi-
ﬁed that activation of PERK-eIF2α-ATF4 pathway under ER stress
condition is required for hepatic VLDL receptor up-regulation in
hepatocytes, which is responsible for intracellular accumulation of
triglycerides and hepatic steatosis (Jo et al., 2013). Furthermore,
attenuation of global translation by activation of PERK-eIF2α
pathway also decreases ApoB expression, which further promotes
hepatic steatosis.
ATF6 PATHWAY
Both ATF6 and SREBPs are activated by the same proteases (S1P
and S2P) in the Golgi (Sakai et al., 1998; Ye et al., 2000; Horton
et al., 2002b). Several independent studies have shown that ATF6
and XBP-1 share similar DNA binding speciﬁcities (Yoshida et al.,
2000, 2001; Acosta-Alvear et al., 2007; Misiewicz et al., 2013). In
addition, ATF6 and XBP-1 are able to form a heterodimer and
regulate down-stream target genes (Yamamoto et al., 2007). Sev-
eral recent studies in ATF6α knockout mice indicate that ATF6
also plays an important role in regulating hepatic lipid home-
ostasis (Rutkowski et al., 2008; Yamamoto et al., 2010). Similar to
IRE1α, deletion of ATF6α does not result in an apparent phe-
notype under physiological conditions. However, under ER stress
conditions,ATF6α knockoutmice exhibited severe liver injury and
hepatic steatosis caused by inhibition of fatty acid β-oxidation and
VLDL formation (Yamamoto et al., 2010). In addition, the CHOP
expression is signiﬁcantly up-regulated while PPARα expression
and ApoB-100 protein levels are decreased in the livers of ATF6α
knockout mice (Rutkowski et al., 2008; Yamamoto et al., 2010).
A recent study in zebraﬁsh with fatty liver disease demonstrated
that ER stress induces fatty liver disease. During chronic ER stress,
ATF6 promotes steatosis. However, ATF6 prevents acute ER stress-
induced steatosis. This study suggest that ATF6 can play both
protective and pathological roles in fatty liver disease (Cinaroglu
et al., 2011).
ER STRESS MASTER REGULATOR-GRP78/BiP
GRP78/BiP is a glucose-regulated protein that functions as a
molecular chaperone in the ER (Mote et al., 1998). As described
in previous section, GRP78 acts as a master regulator of the
activation of UPR signaling pathways. Numerous studies have
indicated that ER stress is an important component of the
hepatic steatosis and insulin resistance in obese rodent mod-
els (Kammoun et al., 2009; Chen et al., 2013; Teodoro-Morrison
et al., 2013). GRP78 plays a critical role in maintaining hep-
atic lipid homeostasis. Overexpression of GRP78 prevents ER
stress-induced SREBP-1c proteolytic cleavage and reduced hepatic
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steatosis (Kammoun et al., 2009). It also has been reported
that overproduction of GRP78 prevents palmitate-induced ER
stress and cytotoxicity in human HepG2 cells (Gu et al., 2010)
and high fat diet-induced type 2 diabetes in mouse mod-
els (Teodoro-Morrison et al., 2013). A most recent study fur-
ther indicated that GRP78 is able to prevent oxidative stress-
induced injury by inhibiting lipid peroxidation (Suyama et al.,
2014).
C/EBP HOMOLOGOUS PROTEIN
C/EBP homologous protein is a proapoptotic transcriptional fac-
tor downstream of all three UPR signaling pathways. Numerous
evidences suggest that CHOP activation promotes cell apopto-
sis and induces tissue injury. In absence of CHOP, both cells
and animals are protected against various pharmacological and
physiological insults (Tabas and Ron, 2011). It has been shown
that CHOP deﬁciency attenuates cholestasis-induced liver ﬁbrosis
and methionine-choline-deﬁcient (MCD) diet-induced steato-
hepatitis, ﬁbrosis, and carcinogenesis in mice (Tamaki et al., 2008;
Toriguchi et al., 2013). In a murine model of intragastric ethanol
feeding, CHOP null mice have remarkable absence of hepatocellu-
lar apoptosis, but no protection against alcohol-induced steatosis
(Ji et al., 2005). In human liver cell lines, saturated fatty acids
induce ER stress and apoptosis via the PERK/ATF4/CHOP (Cao
et al., 2012). Our recent studies suggest that CHOP is a major
player in human immunodeﬁciency virus protease inhibitor-
induced hepatic lipotoxicity in mice (Wang et al., 2013). Studies
done by Chikka et al. (2013) further suggest CHOP has a non-
apoptotic role in regulating hepatic metabolic genes during ER
stress. In addition, a recent study reported that CHOP expres-
sion is up-regulated in human hepatocellular carcinoma (HCC)
and two mouse HCC models. CHOP expression contributes
to hepatic carcinogenesis by promoting inﬂammation and cell
apoptosis (DeZwaan-McCabe et al., 2013). These studies indicate
CHOP is a common contributing factor in ER stress-induced liver
injury.
THERAPEUTIC POTENTIAL TARGETING ER STRESS IN
METABOLIC DISEASES
Chronic ER stress has been implicated in the pathogenesis of
metabolic diseases such as a diabetes, obesity, cardiovascular dis-
eases as well as fatty liver disease (Colgan et al., 2011; Malhi and
Kaufman, 2011; Mollica et al., 2011; Bechmann et al., 2012; Cnop
et al., 2012). Targeting the speciﬁc UPR signaling pathways to
attenuate ER stress and UPR activation would provide opportu-
nities in developing new therapeutic strategies in a wide array
of diseases. Several studies have shown the promising effects of
small chemical chaperones on alleviating the UPR activation in
animal models, such as 4-phenylbutyric acid (4-PBA) and tau-
roursodeoxycholic acid (TUDCA; Heubi et al., 2002; Ozcan et al.,
2006; Basseri et al., 2009; Engin and Hotamisligil, 2010; Lee et al.,
2010). Both 4-PBA and TUDCA have been approved by US Food
and Drug Administration (FDA) for treating children with urea-
cycle disorders and cholestatic liver disease, respectively. However,
more clinical studies are needed to validate the potential applica-
tion of these chemical chaperones in treating ER stress-associated
metabolic diseases.
CONCLUSION
Hepatic lipid homeostasis requires integration of multiple sig-
nals. A signiﬁcant amount of evidence indicates that activation
of ER stress signaling pathways play a critical role in various
diseases associatedwith dysregulation of hepatic lipidmetabolism.
Although acute ER stress response helps restore ER homeosta-
sis, prolonged or chronic ER stress activation contributes to
development of various metabolic diseases including NAFLD,
type 2 diabetes, and atherosclerosis by inducing widespread
pathologic apoptosis (Tabas and Ron, 2011). The balance of
the UPR signaling pathways, such as ATF6, IRE1/XBP1, and
PERK/ATF4, is critical for maintaining cellular homeostasis.
However, the exact mechanisms underlying ER stress-induced
disruption of hepatic lipid homeostasis remains to be fully iden-
tiﬁed. Recent studies have shown that ER stress is also closely
linked to inﬂammation and autophagy, which are two impor-
tant players in regulating hepatic lipid metabolism (Ogata et al.,
2006; Yorimitsu et al., 2006; Hoyer-Hansen and Jaattela, 2007;
Yorimitsu and Klionsky, 2007; Hotamisligil, 2010; Hummasti
and Hotamisligil, 2010; Mollica et al., 2011; Qiu et al., 2011;
Adolph et al., 2012; Hasnain et al., 2012; Kolattukudy and Niu,
2012). The contribution of autophagy to lipid metabolism has
been reviewed in several excellent reviews (Singh, 2010; Amir
and Czaja, 2011; Czaja, 2011; Ding et al., 2011; Lavallard et al.,
2012). Elucidating the signaling pathways of ER stress and its
intertwining with other intracellular signaling components not
only furthers our current understanding of lipid metabolism
in a central metabolic organ, but also helps develop an effec-
tive approach that can be used to treat patients with metabolic
diseases.
A growing body of evidence links ER stress and UPR activation
to diseases associated with lipid metabolism. The UPR signaling
pathways and activation of transcription factors such as XBP1
and ATF6 have novel roles in controlling the transcriptional reg-
ulation of lipogenesis. While IRE1α itself is protective against
ER-stress-induced lipogenesis and hepatic steatosis, its down-
stream mediator XBP1 promotes transcription of genes involved
in fatty acid and cholesterol biosynthesis. Phosphorylation of
eIF2α downstream of PERK affects the transcriptional activity of
C/EBPs, PPARγ, and SREBP-1c thereby leading to lipid accumula-
tion and hepatic steatosis under high-fat-diet conditions. Similar
to IRE1α, ATF6α also protects against ER stress-induced steatosis
and lipid droplet formation in mice. Furthermore, nuclear ATF6
attenuates SREBP2-mediated lipogenesis. The exact mechanisms
by which ER stress signaling pathways affect lipid homeostasis are
incompletely understood. Given the temporal differences in the
activation of the three arms of the UPR, a closer examination of
each branch of the UPR will allow for a better understanding of
how various components of this signaling network impact lipo-
genesis and disease progression. Such studies will further enhance
our understanding of the biological and pharmacological tools
needed to effectively treat ER-associated diseases.
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